Key facts
- This page summarizes Gerrard Schmid's Form 4 filing for DIEBOLD NIXDORF, Inc (DBD).
- 3 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2022, 20:14.
Gerrard Schmid - 05 Feb 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- DBD
- Reported as of
- 05 Feb 2022
- Net transaction value
- +$337,532
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2022, 20:14:32 UTC
- Prior SEC filing
- 31 Jan 2022
- Next SEC filing
- 26 May 2022
- Source filing
- View source filing
- Reporting owner signature
- Jonathan B. Leiken, Attorney-in-fact for Gerrard Schmid
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gerrard Schmid filed Form 4 for DIEBOLD NIXDORF, Inc (DBD) on 08 Feb 2022.
Change
- Previous filing in this sequence was filed on 31 Jan 2022.
- Current net transaction value: +$337,532.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DBD
transaction
Common Shares
Tax liability
- Transaction value
- $277,629
- Shares
- -33,652
- Change %
- -6.7%
- Price
- $8.25*
- Shares after
- 471,206
- Date
- 05 Feb 2022
- Ownership
- Direct
- Footnotes
- F1, F2
DBD
transaction
Common Shares
Award
- Transaction value
- $1,256,722
- Shares
- +152,330
- Change %
- +32%
- Price
- $8.25*
- Shares after
- 623,536
- Date
- 06 Feb 2022
- Ownership
- Direct
- Footnotes
- F2, F3
DBD
transaction
Common Shares
Tax liability
- Transaction value
- $641,561
- Shares
- -77,765
- Change %
- -12%
- Price
- $8.25*
- Shares after
- 545,771
- Date
- 06 Feb 2022
- Ownership
- Direct
- Footnotes
- F2, F4
DBD
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 05 Feb 2022
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DBD
holding
Derivative
Non-Qualified Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 192,049
- Date
- 05 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 192,049
- Exercise price
- $15.35
- Footnotes
- F5
DBD
holding
Derivative
Non-Qualified Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 676,814
- Date
- 05 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 676,814
- Exercise price
- $4.49
- Footnotes
- F6
DBD
holding
Derivative
Non-Qualified Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 34,678
- Date
- 05 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 34,678
- Exercise price
- $13.98
- Footnotes
- F6
DBD
holding
Derivative
Non-Qualified Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 253,907
- Date
- 05 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 253,907
- Exercise price
- $13.15
- Footnotes
- F6
DBD
holding
Derivative
Performance Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 56,059
- Date
- 05 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 56,059
- Exercise price
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
Footnote F2
Number includes restricted stock units.
Footnote F3
Reflects delivery of shares earned under the 2021 Performance Award Agreement.
Footnote F4
Reflects withholding of shares to satisfy the Reporting Person's tax obligations in connection with the vesting of shares of restricted common stock of the Issuer.
Footnote F5
Option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
Footnote F6
Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
Footnote F7
Award subject to a three-year performance period during which the Company's stock price must appreciate at least 25% in order for the grant to vest. Performance will be measured on the anniversaries of the grant date, and the award will vest upon the first achievement of the performance, but will payout in shares on a pro-rata annual basis after performance is satisfied. If the stock performance condition is not met by the third anniversary of the date of grant, then the entire award is forfeited.